Rolf Barth to Maintenance Chemotherapy
This is a "connection" page, showing publications Rolf Barth has written about Maintenance Chemotherapy.
Connection Strength
0.639
-
Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts. Clin Transplant. 2019 06; 33(6):e13531.
Score: 0.639
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.